Author

M. Francis

University of Colorado AnschutzORCID 0000-0002-1228-1570Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

M. Francis4 papers

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Maki NakayamaiD· 1 shared Matthew A. BurchilliD· 1 shared Michael C. YarnelliD· 1 shared Neetigyata Singh· 1 shared Ross M. KedliD· 1 shared Terry J. FryiD· 1 shared Winston HibleriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Maki NakayamaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintNov 10, 2025

High Precision Peptide-MHC Class I CARs Enhance In Vivo Killing ofTargeted CD8 T Cells to Prevent Type 1 Diabetes in Novel RIP-mOVA Model

M. Francis, Winston Hibler, Michael C. Yarnell…·Maki Nakayama

This paper develops a peptide-MHC Class I CAR platform that enhances in vivo killing of antigen-specific CD8 T cells and prevents type 1 diabetes in a novel RIP-mOVA model.

DOI 10.1101/2025.11.10.687586

mouseproteomics

𝕏 PostBluesky